Meanwhile, lncRNA CHROMR overexpression enhanced DLBCL cell proliferation, invasion, inhibited DLBCL cell apoptosis, and insensitized DLBCL cells to rituximab treatment in vitro. Here, CHROMR is linked to diffuse large B-cell lymphoma.